The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer.

Autor:	Jr.Garrison, Louis P.1,2 lgarrisn@u.washington.edu, Babigumira, Joseph B.1,2, Masaquel, Anthony3, Wang, Bruce C.M.4, Lalla, Deepa3, Brammer, Melissa3
Zdroj:	Value in Health. Jun2015, Vol. 18 Issue 4, p541-546. 6p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect